Opioid Use Disorder Treatment Bundle

Featuring content from our annual Pharmacy Practice Seminar, Psychiatric Pharmacotherapy Update and Health Systems Practice Seminar

About

The sessions in this course bundle were recorded during the 2023 Pharmacy Practice Seminar, Psychiatric Pharmacotherapy Update and Health Systems Practice Seminar. They have been optimized for on-demand viewing and grouped together for your convenience.

Learning Objectives

Learning Objectives for each of the three sessions are located in the session tabs below.

A Note About CPE Credit

Please note that if you have taken any of the courses in this bundle before, you will not be able to claim credit for the course again. The CPE monitor will only allow one credit to be claimed per UAN, meaning that credit can only be claimed once, even if you watch the video multiple times.

Instructions

This program consists of one video and downloadable resources in PDF format.

To begin, scroll to the bottom of this page and click the green "Purchase Now" button. You will then be asked to log in or create an account. If you have taken a course with UT Pharmacy CE previously, be sure to use the same login as before. Once you are logged in, you can complete the registration and then take the course. After you have registered, you will be able to access this course at any time until the expiration date.

Speaker information and disclosures can be found in the tabs below.

Fee

$30.00

CE Hours

3.00

CE Units

0.300

Activity Type

Knowledge

Support/Credits

Continuing Education Credit

The University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This online activity is approved for 0.30 CEUs (3.00 contact hours) of continuing education credit. To receive 3.00 contact hours of CE credit, the participant must watch the included video in its entirety, pass the online post-test ( >70% within 5 attempts), and complete the online evaluation. Upon successfully completing the course evaluation, the continuing pharmacy education credits will automatically be uploaded to CPE Monitor (allow 3-7 days).

Breaking Issues in Opioid Use Disorder Treatment and Harm Reduction

Breaking Issues in Opioid Use Disorder Treatment and Harm Reduction

Learning Objectives

Summarize recent legal and regulatory changes impacting OUD care
Identify barriers and facilitators to pharmacist collaboration in OUD care
Plan to integrate evidence-based OUD care in pharmacy practice

About the Speaker

Lucas G. Hill, Pharm.D., BCACP

Clinical Associate Professor
The University of Texas at Austin College of Pharmacy

Director, Pharmacy Addictions Research & Medicine Program

Lucas G. Hill graduated from the University of Missouri–Kansas City School of Pharmacy and completed a combined family medicine residency and faculty development fellowship at the University of Pittsburgh Medical Center. He is now a clinical associate professor at The University of Texas at Austin College of Pharmacy where he serves as director of the Pharmacy Addictions Research and Medicine (PhARM) Program and holds the Bergen Brunswig Corporation Centennial Fellowship. Dr. Hill is the principal investigator for a Texas Targeted Opioid Response project which seeks to address the opioid crisis in Texas by educating health professionals and conducting pragmatic research. He is an editorial board member for the Journal of the American College of Clinical Pharmacy and a past chair of the American Association of Colleges of Pharmacy Substance Use Disorder Special Interest Group. Dr. Hill has been recognized with several prestigious national awards, including the American College of Clinical Pharmacy New Educator Award and the American Pharmacists Association Generation Rx Award of Excellence.

Disclosure: Dr. Hill does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).

Activity Number

0067-0000-23-134-H08-P/T

Release Date: Sep 23, 2023

Credit Expiration Date: Sep 22, 2026

CE Hours

1.00

Opioid Use Disorder: A Treatment Strategy Update

Opioid Use Disorder: A Treatment Strategy Update

Learning Objectives

Summarize recent legal and regulatory changes impacting OUD care
Compare approved formulations of medications for OUD
Describe challenges in pharmacy access to buprenorphine

About the Speaker

Lindsey J. Loera, Pharm.D.

Assistant Professor of Practice

Assistant Director, Pharmacy Addictions Research & Medicine (PhARM) Program

The University of Texas at Austin College of Pharmacy

Dr. Lindsey J. Loera graduated from the University of Texas at Austin College of Pharmacy (UTCOP) and completed a two-year postgraduate research and teaching fellowship with the Pharmacy Addictions Research & Medicine (PhARM) Program. She is now an assistant professor of practice at the UTCOP and is the assistant director of the PhARM Program. In these roles, Dr. Loera conducts research that supports the Texas Targeted Opioid Response initiative and provides instruction in pharmacotherapy and interprofessional collaboration courses. In addition to these appointments, she serves as a faculty co-advisor to the UTCOP collegiate chapter of the American Association of Psychiatric Pharmacists (UT-AAPP). Dr. Loera has been recognized with prestigious research awards from ACCP and AACP. She is a recipient of the 2020 UTCOP Pharmacy Mortar & Pestle Award, a 2019 United States Public Health Service Excellence in Public Health Pharmacy Award, and the college's 2018 Benjamin Reed Leader in Pharmacy Award.

Disclosure: Dr. Lindsey Loera does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).

Activity Number

0067-0000-23-162-H08-P/T

Release Date: Oct 26, 2023

Credit Expiration Date: Oct 25, 2026

CE Hours

1.00

Managing Buprenorphine in Hospitalized Patients with Opioid Use Disorder

Managing Buprenorphine in Hospitalized Patients with Opioid Use Disorder

Learning Objectives

Discuss buprenorphine management in both the initiation and maintenance phases
Discuss challenging clinical scenarios, including patients with acute pain, and shared decision-making regarding buprenorphine therapy in the peri-operative period

About the Speaker

Kristin Janzen, Pharm.D., BCPS

Clinical Assistant Professor, Pharmacy Practice

The University of Texas at Austin College of Pharmacy

Internal Medicine Clinical Specialist, Dell Seton Medical Center

Kristin Janzen is a Clinical Assistant Professor at the University of Texas at Austin College of Pharmacy. After graduating from UT College of Pharmacy, she completed a combined PGY1 & 2 Pharmacotherapy residency at Butler University and Indiana University Health in Indianapolis, IN. She currently practices at Dell Seton Medical Center at the University of Texas in Internal Medicine, where she precepts fourth-year Pharm.D. students and pharmacy residents on academic internal medicine rotations. She teaches throughout the didactic curriculum at the UT College of Pharmacy, focusing on pharmacotherapeutics, clinical pharmacokinetics, and application-based pharmacy practice labs. She has been recognized for both didactic and experiential teaching and has been awarded the UT Austin College of Pharmacy Educator of the Year, the Austin-Temple-Waco Region Preceptor of the Year, and Wm. Arlyn Koesel Preceptor of the Year Awards. She has also been recognized by the UT Center of Health Interprofessional Practice and Education (IPE) as a Health IPE Fellow. Her research and teaching interests focus on student preparedness for residency, interprofessional education, and core medicine disease states, such as pulmonology, cardiology, and diabetes.

Disclosure: Dr. Janzen does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).

Activity Number

0067-0000-23-056-H08-P/T

Release Date: Jun 23, 2023

Credit Expiration Date: Jun 22, 2026

CE Hours

1.00